Raffaella Balena Selected Research

BIM 51077

7/2009

Treatment with the human once-weekly glucagon-like peptide-1 analog taspoglutide in combination with metformin improves glycemic control and lowers body weight in patients with type 2 diabetes inadequately controlled with metformin alone: a double-blind placebo-controlled study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raffaella Balena Research Topics

Disease

8	Type 2 Diabetes Mellitus (MODY) 09/2013 - 07/2009
5	Body Weight (Weight, Body) 03/2013 - 07/2009
5	Weight Loss (Weight Reduction) 03/2013 - 07/2009
4	Injection Site Reaction 03/2013 - 03/2012
3	Nausea 03/2013 - 07/2012
3	Vomiting 03/2013 - 07/2012
1	Insulin Resistance 09/2013
1	Hypersensitivity (Allergy) 03/2013
1	Overweight 03/2013

Drug/Important Bio-Agent (IBA)

7	taspoglutideIBA 09/2013 - 07/2009
6	Glucose (Dextrose)FDA LinkGeneric 09/2013 - 07/2009
5	Metformin (Glucophage)FDA LinkGeneric 09/2013 - 07/2009
3	Glucagon-Like Peptide 1 (GLP 1)IBA 09/2013 - 07/2009
1	Glucagon (Glukagon)FDA Link 09/2013
1	Insulin (Novolin)FDA Link 09/2013
1	2,4-thiazolidinedione (thiazolidinedione)IBA 03/2013
1	Exenatide (Byetta)FDA Link 03/2013
1	Glucagon-Like Peptide-1 ReceptorIBA 03/2013
1	Blood Glucose (Blood Sugar)IBA 02/2013
1	Hemoglobins (Hemoglobin)IBA 02/2013
1	Sitagliptin Phosphate (Januvia)FDA Link 12/2012
1	Pioglitazone (Actos)FDA Link 07/2012
1	Hypoglycemic Agents (Hypoglycemics)IBA 03/2012
1	Pharmaceutical PreparationsIBA 03/2012
1	GlucokinaseIBA 11/2010
1	piragliatinIBA 11/2010
1	BIM 51077IBA 07/2009

Therapy/Procedure

7	Glycemic Control 09/2013 - 07/2009
2	Therapeutics 02/2013 - 07/2012